FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid TumorsLeigh Marcus, Richard Pazdur, Steven J. Lemery et al.|Clinical Cancer Research|2019Cited by 1.2k
First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the IndicationSteven J. Lemery, Richard Pazdur, Patricia Keegan|New England Journal of Medicine|2017Cited by 657
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma MultiformeMartin H. Cohen, Richard Pazdur, Yuan Li Shen et al.|The Oncologist|2009Cited by 646
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based ChemotherapyDickran Kazandjian, Richard Pazdur, Daniel L. Suzman et al.|The Oncologist|2016Cited by 478
Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Comparing Transthoracic versus Transesophageal Echocardiographic GuidanceSalim S. Hayek, Stamatios Lerakis, Vasilis Babaliaros et al.|Journal of the American Society of Echocardiography|2017Cited by 42